Moreover, autophagy activator RAP, inhibitor 3-MA and Atg7 siRNA were used to verify the role of AMPK/mTOR-mediated autophagy in the treatment of metabolic syndrome by KD. Here, ATG7 is linked to metabolic syndrome.